![](/img/cover-not-exists.png)
A Double-Blind Randomized Discontinuation Phase-II Study of Sorafenib (BAY 43–9006) in Previously Treated Non–Small-Cell Lung Cancer Patients: Eastern Cooperative Oncology Group Study E2501
Wakelee, Heather A., Lee, Ju-Whei, Hanna, Nasser H., Traynor, Anne M., Carbone, David P., Schiller, Joan H.Volume:
7
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e31826149ba
Date:
October, 2012
File:
PDF, 404 KB
english, 2012